IP Library › Granted Patent US 12,428,640
Granted Patent B2
US 12,428,640 · App. 16/534,667 · Granted Sep 30, 2025

Methods to modulate protein translation efficiency

Inventor: Sergej Djuranovic (St. Louis, MO)
Assignee: Washington University
C12N15/113C12N15/70C12N2830/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,428,640
App. No.
16/534,667
Granted
Sep 30, 2025
Kind
B2
Abstract

The present disclosure relates to compositions and methods to modulate the level of expression of a protein in a deliberate manner (i.e., tunable regulation of expression) with only a minimal change to the genetic sequence of the gene of interest. The present disclosure therefore also provides compositions and methods to predictably alter protein abundance.

Claims (9)

1. A method of increasing the level of expression of a protein, the method comprising:

inserting a polynucleotide sequence into a nucleic acid sequence encoding a first protein of interest to produce a modified nucleic acid sequence encoding a second protein, wherein the nucleic acid encoding the first protein of interest comprises a coding region encoding the first protein of interest, wherein the coding region comprises a first, a second, a third, a fourth and a fifth codon in consecutive order, wherein the first codon is located at a 5′-most end of the coding region, and wherein

(a) the polynucleotide sequence is inserted between the second and third codons of the coding region and the polynucleotide sequence is selected from AAT, AAC, AAATAT, AAATAC, AACTAT, AACTAC, AAGTAT, AAGTAC, AATTAT, AATTAC, AAATATTAT, AAATACTAT, AACTATTAT, AACTACTAT, AAGTATTAT, AAGTACTAT, AATTATTAT, AATTACTAT, AAATATTAC, AAATACTAC, AACTATTAC, AACTACTAC, AAGTATTAC, AAGTACTAC, AATTATTAC, or AATTACTAC;

(b) the polynucleotide sequence is inserted between the third and fourth codons of the coding region and the polynucleotide sequence is selected from AAT, AAC, TAT, TAC, ATT, ATC, ATA, TTA, CTT, AAATAT, AAATAC, AACTAT, AACTAC, AAGTAT, AAGTAC, AATTAT, or AATTAC;

(c) the polynucleotide sequence is inserted between the fourth and fifth codons of the coding region and the polynucleotide sequence is selected from TAT, TAC, ATA, ATC, ATT, AGA, TTA, CTT, or CTA;

and expressing the modified nucleic acid sequence in a cell or in a cell-free transcription/translation system thereby increasing the amount of second protein translated as compared to the amount of first protein translated, wherein the polynucleotide sequence does not encode a stop codon recognizable by the cell or the cell-free system.

2. The method of claim 1 , wherein the polynucleotide sequence does not encode a methionine when read in frame.

3. The method of claim 1 , wherein the first protein and the second protein have the same amino acid sequence.

4. The method of claim 1 , wherein the first protein and the second protein have a different amino acid sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2019
From: DJURANOVIC, SERGEJ
To: WASHINGTON UNIVERSITY
Reel/Frame 050371/0969 →
Continuity (2)
Provisional Application 62764577 · Aug 9, 2018
Related Publication 20200048634A1 · Feb 13, 2020
References Cited (36)
US 4873316A · Meade et al. · 1989 [cited by applicant]
US 6566495B1 · Fodor et al. · 2003 [cited by applicant]
US 11603553B2 · Djuranovic · 2023 [cited by examiner]
EP 0264166A1 · 1988 [cited by applicant]
WO WO2016086988A1 · 2016 [cited by examiner]
Voges et al. “Analyzing and enhancing mRNA translational efficiency in an [cited by examiner]
Koutmou et al. “Ribosomes slide on lysine-encoding homopolymeric A stretches.” Elife 4 (2015): e05534 (Year: 2015). [cited by examiner]
Amann, E. et al., “Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in [cited by applicant]
Arthur, L. et al., “Translational control by lysine-encoding A-rich sequences,” Sci. Adv., Jul. 2015, pp. 1-11, vol. 1, e1500154. [cited by applicant]
Atomi, H. et al., “Overview of the genetic tools in the Archaea,” Front. Microbiol, Oct. 2012, pp. 1-13, vol. 3, No. 337. [cited by applicant]
Baldari, C. et al., “A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1beta in [cited by applicant]
Banerji, J. et al., “A Lymphocyte-Specific Cellular Enhancer Is Located Downstream of the Joining Region in Immunoglobulin Heavy Chain Genes,” Cell, Jul. 1983, pp. 729-740, vol. 33, No. 3. [cited by applicant]
Boshart, M. et al., “A Very Strong Enhancer Is Locate Upstream of an Immediate Early Gene of Human Cytomegalovirus,” Cell, Jun. 1985, pp. 521-530, vol. 41. [cited by applicant]
Byrne, G. et al., “Multiplex gene regulation: A two-tiered approach to transgene regulation in transgenic mice,” PNAS, Jul. 1989, pp. 5473-5477, vol. 86. [cited by applicant]
Calame, K. et al., “Transcriptional Controlling Elements in the Immunoglobulin and T Cell Receptor Loci,” Adv. Immunol., 1988, pp. 235-275, vol. 43. [cited by applicant]
Camper, S. et al., “Postnatal repression of the alpha-fetoprotein gene is enhancer independent,” Genes Dev., 1989, pp. 537-546, vol. 3. [cited by applicant]
Edlund, T. et al., “Cell-Specific Expression of the Rat Insulin Gene: Evidence for Role of Two Distinct 5′ Flanking Elements,” Sci., Nov. 1985, pp. 912-916, vol. 230, No. 4728. [cited by applicant]
Gamble, C. et al., “Adjacent Codons Act in Concert to Modulate Translation Efficiency in Yeast,” Cell, Jul. 2016, pp. 679-690, vol. 166. [cited by applicant]
Goodman, D. et al. “Causes and Effects of N-Terminal Codon Bias in Bacterial Genes,” Sci., Oct. 2013, pp. 475-479, vol. 342, No. 6157. [cited by applicant]
Kaufman, R. et al., “Translation efficiency of polycistronic mRNAs and their utilization to express heterologous genes in mammalian cells,” EMBO J., 1987, pp. 187-193, vol. 6, No. 1. [cited by applicant]
Kessel, M. et al., “Murine Developmental Control Genes,” Sci., Jul. 1990, pp. 374-379, vol. 249, No. 4967. [cited by applicant]
Kurjan, J. et al., “Structure of a Yeast Pheromone Gene (MFalpha): A Putative alpha-Factor Precursor Contains Four Tandem Copies of Mature alpha-Factor,” Cell, Oct. 1982, pp. 933-943, vol. 30, No. 3. [cited by applicant]
Navon, S. et al., “Amino acid sequence repertoire of the bacterial proteome and the occurrence of untranslatable sequences,” PNAS, Jun. 2016, pp. 7166-7170, vol. 113, No. 26. [cited by applicant]
O'Hare, K. et al., “Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase,” PNAS, Mar. 1981, pp. 1527-1531, vol. 78, No. 3. [cited by applicant]
Pinkert, C. et al., “An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice,” Genes Dev., 1987, pp. 268-277, vol. 1. [cited by applicant]
Presnyak, V. et al., “Codon Optimality Is a Major Determinant of mRNA Stability,” Cell, Mar. 2015, pp. 1111-1124, vol. 160. [cited by applicant]
Queen, C. et al., “Immunoglobulin Gene Transcription Is Activated by Downstream Sequence Elements,” Cell, Jul. 1983, pp. 741-748, vol. 33, No. 3. [cited by applicant]
Rockett, J. et al., “DNA arrays: technology, options and toxicological applications,” Xenobiotica, 2000, pp. 155-177, vol. 30, No. 2. [cited by applicant]
Schultz, L. et al., “Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virus,” Gene, 1987, pp. 113-123, vol. 54, No. 1. [cited by applicant]
Seed, B., “An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2,” Nature, Oct. 1987, pp. 840-842, vol. 329. [cited by applicant]
Smith, D. et al., “Single-step purification of polypeptides expressed in [cited by applicant]
Takebe, Y. et al., “SRalpha Promoter: an Efficient and Versatile Mammalian cDNA Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal R… [cited by applicant]
Tuller, T. et al., “An Evolutionary Conserved Mechanism for Controlling the Efficiency of Protein Translation,” Cell, Apr. 2010, pp. 344-354, vol. 141. [cited by applicant]
Verma, M. et al., “Short translational ramp determines efficiency of protein synthesis,” bioRxiv, Mar. 9, 2019; 26 pgs. [cited by applicant]
Winoto, A. et al., “A novel, inducible and T cell-specific enhancer located at the 3′ end of the T cell receptor alpha ocus,” EMBO J., 1989, pp. 729-733, vol. 8, No. 3. [cited by applicant]
Yoshioka, N. et al., “Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA,” Cell Stem Cell, Aug. 2013, pp. 246-254, vol. 13. [cited by applicant]